NSE: JYOTHYLAB | BSE: 532926

Expensive Underperformer

Download real time

338.05 3.80 (1.14%)

43.27% Fall from 52W High

373.4K NSE+BSE Volume

NSE 23 May, 2025 3:31 PM (IST)

12,413.7

Market Cap

Below industry Median

0.5

Beta 1Year

Very Low volatility

Jyothy Labs Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for JYOTHYLAB, BSE:532926 Jyothy Labs Ltd.

Jyothy Labs Ltd.

25 Oct 2016, 12:00AM

338.05

1.14%

Jyothy_Labs_2QFY17_Result_Update

Hold: Jyothy Labs Ltd.

Reliance Securities

Jyothy Laboratories (JYL) has posted 5.7% yoy growth in net operating income to Rs4.1bn in 2QFY17 on the back of volume growth of 8%. Its consolidated EBITDA grew by 28% yoy to Rs637mn, while net profit surged by 61.1% yoy to Rs320mn. We estimate 13.1% & 19.3% CAGR in Revenues & EBITDA through FY16-18E. The stock has given impressive returns of 25% since our upgrade recommendation post 1QFY17 numbers. While we continue to remain positive on the medium-term growth prospects of JYL, the stock is fairly valued at 32x FY18E earnings, thus the near-term stock performance of JYL is likely to remain muted. Hence, we revise our recommendation on the stock to...

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

20 Sep 2016

338.05

1.14%

Jyothy Laboratories Ltd: Healthy Volumes and Higher Margins ... (Sep 20, 2016)

Hold: Jyothy Labs Ltd.

Karvy

Healthy Volumes and Higher Margins on the Back of Softer Input Costs: Jyothy Laboratories Ltd (JLL) has delivered healthy volume growth of 10.2% in Q1FY17, when compared to 5.6% volume growth in Q1FY16. The company has reported total income from operations at Rs.4403 Mn during this quarter, clocking8.9% growth YoY when compared to Rs.4043 Mn in Q1FY16 on the back of double digit growth in volumes. The company's EBITDA margin improved by 368 bps to reach 18.0% on the back of lower raw material costs due to slowdown in commodityprices and lower employee costs decreased by employee stock option expenses during the quarter compared with 14.4% during Q1FY16.

Jyothy Labs Ltd. has an average target of 442.00 from 5 brokers.

Jyothy Labs Ltd.

17 Aug 2016

338.05

1.14%

Jyothy Laboratories Ltd.- Result Update - 17 August 2016

Hold: Jyothy Labs Ltd.

Way2Wealth

EBIDTA grew by 17.2% Y-O-Y to `80.9crs in the quarter. quarter EBIDTA Margins were at a record high, and expanded by ~130bps to 18.4 4%. This was due to an increase in...

Sharekhan decreased Buy price target of Jyothy Labs Ltd. to 395.0 on 21 May, 2025.

Jyothy Labs Ltd.

12 Aug 2016

338.05

1.14%

Jyothy Laboratories

Hold: Jyothy Labs Ltd.

ICICI Securities Limited

Jyothy Labs (JLL) reported net sales growth of 8.7% YoY to | 422 crore (I-direct estimate: | 441 crore) on the back of 10.3%, 9.4% & 14.1% growth in fabric care, dishwashing & personal care segments respectively. However, household insecticides segment declined 11.4%. Consolidated revenues grew 8.9% on the back of 10.2% volume growth .Power brand sales grew 8% (9.6% volume growth). Ujala, Margo, Exo, Henko, Pril grew 10.8%, 12.2%, 10%, 9.6% & 8.4%, respectively. However, Maxo reported a decline of 11.3% due to extended summer impacting insecticide sales adversely. ICICI Securities Limited value the stock at 27x its FY18E EPS of | 12.1 to arrive at a target price of | 328/share with BUY rating.

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

11 Aug 2016

338.05

1.14%

Jyothy Labs - 1QFY17 Result Update

Buy: Jyothy Labs Ltd.

Reliance Securities

Broad based growth; Reasonable Valuations Warrant an Upgrade Backed by 10.2% volume growth, Jyothy Laboratories (JYL) reported 8.9% yoy rise in consolidated sales to Rs4.4bn in 1QFY17. While EBITDA grew 36.9% yoy to Rs791mn, consolidated net profit stood at Rs459mn. Cash profit rose by 25% yoy to Rs544mn in 1QFY17. We expect JYL to post 13% & 14% CAGR in revenues and earnings through FY16-18E. The stock currently trades at reasonable valuation of 25.4x FY18E earnings which coupled with expected uptick in growth makes it an attractive investment opportunity. Hence, we revise our recommendation on the...

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

27 May 2016

338.05

1.14%

Jyothy Laboratories Ltd

Neutral: Jyothy Labs Ltd.

Angel Broking

For 4QY2016, Jyothy Laboratories (JLL) reported a top-line growth of 11.1% yoy to Rs445cr. On account of lower raw material and employee expenses as a percentage of sales, the EBITDA margin expanded by 431bp yoy to 14.1%. Interest expenses declined by 83.7% yoy to Rs1cr while the tax rate was higher at 35% vs 11.4% in 4QFY2015. On account..

Number of FII/FPI investors decreased from 224 to 215 in Mar 2025 qtr

Jyothy Labs Ltd.

26 May 2016

338.05

1.14%

Jyothy Laboratories Ltd.- Result Update - 26 May 2016

Hold: Jyothy Labs Ltd.

Way2Wealth

Power Brand sales grew by 10.3% (9.5% by volume) in FY16. Power Brand sales grew by 13.6 % (Volume 15.3%) in Q4. Operating Profit (including ESOS) for FY16 was at `220.1 crore (13.4%) as compared...

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

24 May 2016, 12:00AM

338.05

1.14%

Jyothy Laboratories

Hold: Jyothy Labs Ltd.

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Jyothy Labs (JLL) reported better than expected numbers on sales & operational front while PAT came in below expectation. Sales growth...

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

24 May 2016, 12:00AM

338.05

1.14%

Jyothy Labs - 4QFY16 Result Update

Accumulate: Jyothy Labs Ltd.

Reliance Securities

Jyothy Laboratories' 4QFY16 results were slightly ahead of our estimates with its consolidated net sales growing by 12.4% to Rs4.5bn (v/s our estimate of Rs4.3bn) and net profit by 31.6% to Rs356mn (v/s our estimate of Rs346mn). Quarterly volume grew by an impressive 13.7% with power brands growing by 15.3%. We expect the Company to deliver revenue and earnings CAGR of 13% & 13.4% through FY16-18E and change...

Sharekhan decreased Buy price target of Jyothy Labs Ltd. to 395.0 on 21 May, 2025.

Jyothy Labs Ltd.

19 Mar 2016

338.05

1.14%

Jyothy Laboratories Ltd: Powerbrands to Offer Attractive Growth Opportunities (Mar 19, 2016)

Buy: Jyothy Labs Ltd.

Karvy

JLL is a multi-product company with strong market position in the fabric whiteners segment on the back of brand name Ujala. JLL has created a unique portfolio named Powerbrands, which includes six brands namely Ujala, Henko, Maxo, Pril, Exo and Margo. Revenue contribution from Powerbrands comes to 88% of the total revenues, which is Rs.12890 Mn in FY15 and growth rates registered for FY15 is 16%. JLL is investing in advertisement and promotional activities to market Powerbrands aggressively to focus on brand building and to maintain growth rate in coming years. Total advertising and promotional expense comes to 12% of the total revenues.

Sharekhan decreased Buy price target of Jyothy Labs Ltd. to 395.0 on 21 May, 2025.

Is Jyothy Labs Ltd. worth buying?

281 Votes:

Buy 80.78%

Sell 11.39%

Hold 7.83%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Neutral SEE REPORTS >

pdf